Mannatech (NASDAQ:MTEX) Earns Buy Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Mannatech (NASDAQ:MTEXFree Report) in a report released on Friday. The brokerage issued a buy rating on the stock.

Mannatech Trading Up 3.8 %

Shares of MTEX opened at $11.87 on Friday. The firm’s fifty day moving average is $8.98 and its two-hundred day moving average is $7.94. The stock has a market cap of $22.37 million, a PE ratio of -14.65 and a beta of 1.18. The company has a quick ratio of 0.74, a current ratio of 1.25 and a debt-to-equity ratio of 0.44. Mannatech has a 52-week low of $6.75 and a 52-week high of $13.00.

Mannatech (NASDAQ:MTEXGet Free Report) last released its quarterly earnings data on Tuesday, November 12th. The company reported ($0.17) EPS for the quarter. The business had revenue of $31.73 million during the quarter. Mannatech had a negative net margin of 1.26% and a negative return on equity of 15.62%.

About Mannatech

(Get Free Report)

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.

Featured Articles

Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.